default author photo

Rebecca C. Arend

University of Alabama at Birmingham

SCHOLARLY PAPERS

6

DOWNLOADS

253

TOTAL CITATIONS

0

Scholarly Papers (6)

Actions:
Email selected abstracts
1.

Genomic Alterations, Molecularly Targeted Therapy, and Survival: A Real-World Endometrial Cancer Molecularly Targeted Therapy Consortium Cohort Study

Number of pages: 33 Posted: 14 Aug 2024
Angeles Alvarez Secord, Victoria L. Bae-Jump, Floor J. Backes, Premal Thaker, Paola Gehrig, Rebecca A. Previs, Lindsay Borden, Samantha Thomas, Amanda Jackson, Gottfried E. Konecny, Linda Duska, Rebecca C. Arend, Jason D. Wright, Bradley R. Corr, G.Larry Maxwell, Casey Cosgrove, Maggie Mullen, Christina Washington, Thomas Herzog, Joshua G. Cohen, June Hou, Stephanie Gaillard, Amanda N. Fader, Andrew Berchuck and Franco Muggia
Duke University, University of North Carolina (UNC) at Chapel Hill - Division of Gynecologic Oncology, affiliation not provided to SSRN, Siteman Cancer Center, affiliation not provided to SSRN, Duke University, University of Oklahoma - University of Oklahoma Health Sciences Center, Duke University, University of Cincinnati - University of Cincinnati Medical Center, University of California, Los Angeles (UCLA) - UCLA Medical Center, University of Virginia, University of Alabama at Birmingham, Columbia University - Irving Medical Center, University of Colorado Denver, Inova Health System - Inova Fairfax Hospital, The James Comprehensive Cancer Center - Division of Gynecologic Oncology, affiliation not provided to SSRN, University of Oklahoma - University of Oklahoma Health Sciences Center, University of Cincinnati, City of Hope National Medical Center, Columbia University - Irving Medical Center, Johns Hopkins University, Johns Hopkins University, Duke University - Medical Center and New York University (NYU) - NYU Langone Health
Downloads 75 (837,727)

Abstract:

Loading...

endometrial cancer, genomic alterations, targeted therapy, survival

2.

Dedicated Research Navigators: A Tool to Eradicate Disparities in Clinical Trial Enrollment?

Number of pages: 17 Posted: 08 Jun 2024
Teresa Boitano, Jaclyn A. Wall, Lia Bos, Gabrielle B. Rocque, Courtney Williams, Haller Smith, J. Michael Straughn, Charles Leath, Warner Huh and Rebecca C. Arend
University of Alabama at Birmingham, University of Alabama at Birmingham, affiliation not provided to SSRN, University of Alabama at Birmingham - Department of Hematology and Oncology, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Alabama at Birmingham, University of Alabama at Birmingham, University of Alabama at Birmingham and University of Alabama at Birmingham
Downloads 63 (933,592)

Abstract:

Loading...

Clinical trial enrollment, disparities in gynecologic oncology, research navigators, decreasing disparities, improving outcomes

3.

Racial and Ethnic Differences and Clinical Outcomes of Patients with High Tumor Mutational Burden, High Microsatellite Instability, and Mismatch Repair Deficiency: Real-World Data from the Multi-Institutional Endometrial Cancer Molecularly Targeted Therapy Consortium (Ecmt2)

Number of pages: 29 Posted: 01 May 2025
Sarah S. Lee, Angeles Alvarez Secord, Steven Friedmann, Erinn M. Hade, Carson Smitherman, Nikita Bisht, Lindsay Borden, Amanda Jackson, Floor J. Backes, Premal Thaker, Rebecca C. Arend, Jason D. Wright, Bradley R. Corr, Emily M. Ko, Gottfried E. Konecny, Sarah Podwika, Victoria L. Bae-Jump, Kari Hacker and Franco Muggia
New York University (NYU) - NYU Langone Health, Duke University, affiliation not provided to SSRN, New York University (NYU) - NYU Langone Health, Duke University - Duke Cancer Institute, Duke University - Duke Cancer Institute, University of Oklahoma - University of Oklahoma Health Sciences Center, University of Cincinnati - University of Cincinnati Medical Center, affiliation not provided to SSRN, Siteman Cancer Center, University of Alabama at Birmingham, Columbia University - Irving Medical Center, University of Colorado Denver, University of Pennsylvania, University of California, Los Angeles (UCLA) - UCLA Medical Center, affiliation not provided to SSRN, University of North Carolina (UNC) at Chapel Hill - Division of Gynecologic Oncology, New York University (NYU) - NYU Langone Health and New York University (NYU) - NYU Langone Health
Downloads 40 (1,183,237)

Abstract:

Loading...

Endometrial cancer, tumor mutational burden, microsatellite instability, mismatch repair deficiency

4.

Platinum-Free Interval and Response to Platinum Retreatment or Lenvatinib/Pembrolizumab in Patients with Recurrent Endometrial Cancer: A Real-World Endometrial Cancer Molecularly Targeted Therapy Consortium Cohort Study

Number of pages: 19 Posted: 02 Dec 2024
Paulina Haight, Marilyn Sanchez, Samantha Thomas, Carson Smitherman, Casey Cosgrove, Victoria L. Bae-Jump, Sarah M. Crafton, Kari Hacker, Emily M. Ko, Thomas C. Krivak, Olivia Lara, Kathleen N. Moore, Maggie Mullen, Franco Muggia, Premal Thaker, Christina Washington, Rebecca C. Arend, Bradley R. Corr, Linda Duska, Amanda Jackson, Gottfried E. Konecny, Jason Wright, Angeles Alvarez Secord and Floor J. Backes
affiliation not provided to SSRN, affiliation not provided to SSRN, Duke University, Duke University - Duke University Hospital, The James Comprehensive Cancer Center - Division of Gynecologic Oncology, University of North Carolina (UNC) at Chapel Hill - Division of Gynecologic Oncology, Allegheny Health Network, New York University (NYU) - NYU Langone Health, University of Pennsylvania, Allegheny Health Network, affiliation not provided to SSRN, University of Oklahoma - Stephenson Cancer Center, affiliation not provided to SSRN, New York University (NYU) - NYU Langone Health, Siteman Cancer Center, University of Oklahoma - University of Oklahoma Health Sciences Center, University of Alabama at Birmingham, University of Colorado Denver, affiliation not provided to SSRN, University of Cincinnati - University of Cincinnati Medical Center, University of California, Los Angeles (UCLA) - UCLA Medical Center, affiliation not provided to SSRN, Duke University and affiliation not provided to SSRN
Downloads 35 (1,249,711)

Abstract:

Loading...

Platinum-free interval, Endometrial Cancer

5.

Real-world overall survival and progression-free survival in patients with advanced epithelial ovarian cancer with wild-type BRCA tumors treated in the US community oncology setting

Number of pages: 26 Posted: 12 Mar 2026
Lei Chen, Lisa Herms, John Murphy, Gregory Patton, Audrey P. Garrett, Mehmet Burcu, Cumhur Tekin, Karin Yamada and Rebecca C. Arend
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and University of Alabama at Birmingham
Downloads 22 (1,424,331)

Abstract:

Loading...

advanced epithelial ovarian cancer, bevacizumab, BRCA, overall survival, progression-free survival, real-world data

6.

Histopathologic Findings among Women with Abnormal Visual Cervical Cancer Screening Reports in Cameroon

Number of pages: 16 Posted: 12 Apr 2026
Simon M. Manga, Ivree Randolph, Lynda Ugwu, Grace Lee, Kathleen Nulah, Florence Manjuh, Comfort Ketu and Rebecca C. Arend
University of Alabama at Birmingham, University of Alabama at Birmingham, University of Alabama at Birmingham, University of Alabama at Birmingham, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and University of Alabama at Birmingham
Downloads 18 (1,470,786)

Abstract:

Loading...

Cameroon, Cervical Cancer, Cervical Intraepithelial Neoplasm Grade 2 or Worse/CIN2+, Diagnosis, Visual Inspection with Acetic Acid, Women